传统腹腔镜与机器人辅助原发性减重手术的结局:MBSAQIP数据库回顾性病例对照研究
本研究基于MBSAQIP 2015-2016数据库,比较机器人辅助与腹腔镜Roux-en-Y胃旁路术(RnYGB)及袖状胃切除术(SG)的围术期结局。机器人辅助RnYGB死亡率及部分并发症更低,但机器人辅助SG手术时间更长、住院更久且部分并发症更高。总体两者均安全,机器人SG未见明确获益且不具成本效益。
要点
- 机器人辅助RnYGB与腹腔镜相比死亡率及出血、输血、手术部位感染更低。
- 机器人辅助SG手术时间及住院时间更长,转开腹及30天干预率更高。
- 机器人SG未显示明确优于腹腔镜SG,且因耗时更长不具成本效益。
核心结论
- 机器人辅助与腹腔镜RnYGB和SG总体均非常安全。
- 机器人辅助胃旁路术与更低的死亡率和并发症相关。
- 机器人辅助SG相比腹腔镜SG未见明确获益,且因手术和住院时间更长而不具成本效益。
研究设计与样本
- 回顾性分析2015和2016年MBSAQIP Participant Use Data File(PUF)。
- 纳入原发性机器人及腹腔镜RnYGB和SG病例,先对非匹配队列描述分析,后行1:3病例对照匹配。
- 按患者人口学和术前合并症匹配病例与对照,比较围术期结局。
主要发现
- 共识别77,991例Roux-en-Y胃旁路术(7.5%机器人辅助)和189,503例袖状胃切除术(6.8%机器人辅助)。
- 机器人辅助RnYGB和SG队列手术时间均显著更高(p < 0.0001)。
- 机器人辅助RnYGB队列死亡率更低(p = 0.05)、输血需求更低(p = 0.005)、总体出血更低(p = 0.04)、手术部位感染(SSI)更低(p = 0.006)。
- 机器人辅助SG队列住院时间更长(p < 0.0001)、转开腹率更高(p < 0.0001)、30天干预更高(p = 0.01)、留置手术引流更高(p < 0.0001)、脓毒症更高(p = 0.01)、器官腔隙SSI更高(p = 0.0002)。
- 机器人SG队列出血更低,死亡率相似。
临床怎么用
- 机器人辅助RnYGB可能降低死亡率和部分并发症,但需权衡手术时间延长。
- 机器人辅助SG未显示明确优势且住院更长,选择时需考虑成本效益。
局限性
- 回顾性研究设计。
- 基于数据库的病例对照匹配,可能存在未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Robotic-assisted bariatric surgery is increasingly performed. There remains controversy about the overall benefit of robotic-assisted (RBS) compared to conventional laparoscopic (LBS) bariatric surgery. In this study, we used a large national risk-stratified bariatric clinical database to compare outcomes between robotic and laparoscopic gastric bypass (RNYGB) and sleeve gastrectomy (SG). METHODS: A retrospective analysis of the 2015 and 2016 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Participant Use Data File (PUF) was performed. Primary robotic and laparoscopic RYNGB and SG were analyzed. Descriptive analysis was performed of the unmatched cohorts, followed by 1:3 case-controlled matching. Cases and controls were matched by patient demographics and pre-operative comorbidities, and peri-operative outcomes compared. RESULTS: 77,991 Roux-en-Y gastric bypass (RnYGB) (7.5% robotic-assisted) and 189,503 SG (6.8% robotic-assisted) cases were identified. Operative length was significantly higher in both the robotic-assisted RnYGB and SG cohorts (p < 0.0001). Outcomes were similar between the robotic-assisted and laparoscopic RnYGB cohorts, except a lower mortality rate (p = 0.05), transfusion requirement (p = 0.005), aggregate bleeding (p = 0.04), and surgical site infections (SSI) (p = 0.006) in the robotic-assisted cohort. Outcomes were also similar between robotic-assisted and laparoscopic SG, except for a longer length of stay (p < 0.0001) and higher rates of conversion (p < 0.0001), 30-day intervention (p = 0.01), operative drain present (p < 0.0001), sepsis (p = 0.01), and organ space SSI (p = 0.0002) in the robotic cohort. Bleeding was lower in the robotic SG cohort and mortality was similar. CONCLUSION: Both robotic-assisted and laparoscopic RnYGB and SG are overall very safe. Robotic-assisted gastric bypass is associated with a lower mortality and morbidity; however, a clear benefit for robotic-assisted SG compared to laparoscopic SG was not seen. Given the longer operative and hospital duration, robotic SG is not cost-effective.
引用
- Acevedo E, Mazzei M, Zhao H, et al. Outcomes in conventional laparoscopic versus robotic-assisted primary bariatric surgery: a retrospective, case-controlled study of the MBSAQIP database. Surg Endosc. 2019. PMID: 31209608. doi:10.1007/s00464-019-06915-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。